Greenberg Traurig Patent Attorney David J. Dykeman to Present at AdvaMed 2012: The MedTech Conference

Greenberg Traurig Patent Attorney David J. Dykeman to Present at AdvaMed 2012: The MedTech Conference

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Boston, MA (PRWEB) October 02, 2012

David J. Dykeman, a shareholder, registered patent attorney, and co-chair of Greenberg Traurig’s Intellectual Property Department in the Boston office, will be a featured speaker at AdvaMed 2012:The MedTech Conference, October 1 - 3, 2012 at the Boston Convention & Exhibition Center in Boston, MA.

On Wednesday, October 3 from 2:15 - 3:30 p.m., Dykeman will present “Prometheus Supreme Court Decision Places Diagnostics Patents at Risk.” Dykeman will moderate a panel of medical technology experts to discuss strategies and best practices for developing strong patent portfolios in the wake of the landmark Prometheus decision by the U.S. Supreme Court on March 20, 2012. The panelists include: Omar Amirana, M.D. of Allied Minds; Amy F. Mendel, Esq. of ZIOPHARM Oncology; and Michael C. Schiffer, Esq. of Beckman Coulter. Attendees will gain valuable insights on: (1) best practices for filing strong patent applications to protect a company’s current core technology and future improvements; (2) compare and contrast the European and US approaches to diagnostic claims; and (3) impact on financing of diagnostic and medtech companies.

A registered patent attorney with over 15 years of experience in patents, intellectual property, and licensing, Dykeman’s practice focuses on securing strategic worldwide intellectual property protection and related business strategy for high-tech clients, with particular expertise in medical devices, life sciences, biotechnology and healthcare IT. Dykeman serves on the Board of Directors of the Massachusetts Medical Device Industry Council (MassMEDIC), and on the Editorial Advisory Board of Medical Device + Diagnostic Industry (MD+DI) Magazine. He was appointed the founding Co-Chair of the ABA Section of Science & Technology Law's Medical Device Committee and serves on the Massachusetts Life Sciences Collaborative Research, Innovation & Commercialization Task Force.

An author of over 35 articles and a speaker at over 30 conferences on medical devices and life sciences intellectual property, Dykeman was honored as a “40 Medtech Innovator Under 40” by MD+DI magazine, and was named one of the top 250 Patent and Technology Licensing Practitioners in the world by Intellectual Asset Management (IAM) Magazine.

About AdvaMed 2012
For the first time ever, AdvaMed 2012: The MedTech Conference, will take place in Boston, one of the largest MedTech clusters in the world. Building on the success of its first five years in Washington, DC, international MedTech executives with regulatory, reimbursement, business development, legal, IP, marketing, quality, compliance, and other key responsibilities will meet in Boston to attend AdvaMed 2012. Along with industry leaders, business development professionals, investors, policy-makers, members of the media, legal experts, consultants, distributors, and other important stakeholders will attend this international conference.

About Greenberg Traurig, LLP
Greenberg Traurig, LLP is an international, full-service law firm with approximately 1750 attorneys serving clients from 35 offices in the United States, Latin America, Europe, the Middle East and Asia. In the U.S., the firm has more offices than any other among the Top 10 on The National Law Journal's 2012 NLJ 250. For additional information, please visit http://www.gtlaw.com.


Contact